Cell MedX Corp
OTC:CMXC

Watchlist Manager
Cell MedX Corp Logo
Cell MedX Corp
OTC:CMXC
Watchlist
Price: 134.435 USD 31 019.21% Market Closed
Market Cap: 40B USD
Have any thoughts about
Cell MedX Corp?
Write Note

Intrinsic Value

CMXC doesn't have a meaningful market cap.
CMXC's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CMXC stock under the Base Case scenario is 3.0E-6 USD. Compared to the current market price of 134.435 USD, Cell MedX Corp is Overvalued by 100%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CMXC Intrinsic Value
3.0E-6 USD
Overvaluation 100%
Intrinsic Value
Price
Worst Case
Base Case
Best Case
How do you feel about CMXC?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Cell MedX Corp

Provide an overview of the primary business activities
of Cell MedX Corp.

What unique competitive advantages
does Cell MedX Corp hold over its rivals?

What risks and challenges
does Cell MedX Corp face in the near future?

Has there been any significant insider trading activity
in Cell MedX Corp recently?

Show all valuation multiples
for Cell MedX Corp.

Provide P/S
for Cell MedX Corp.

Provide P/E
for Cell MedX Corp.

Provide P/OCF
for Cell MedX Corp.

Provide P/FCFE
for Cell MedX Corp.

Provide P/B
for Cell MedX Corp.

Provide EV/S
for Cell MedX Corp.

Provide EV/GP
for Cell MedX Corp.

Provide EV/EBITDA
for Cell MedX Corp.

Provide EV/EBIT
for Cell MedX Corp.

Provide EV/OCF
for Cell MedX Corp.

Provide EV/FCFF
for Cell MedX Corp.

Provide EV/IC
for Cell MedX Corp.

Compare the intrinsic valuations
of Cell MedX Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Cell MedX Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Cell MedX Corp compared to its peers.

Compare the P/E ratios
of Cell MedX Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Cell MedX Corp with its peers.

Analyze the financial leverage
of Cell MedX Corp compared to its main competitors.

Show all profitability ratios
for Cell MedX Corp.

Provide ROE
for Cell MedX Corp.

Provide ROA
for Cell MedX Corp.

Provide ROIC
for Cell MedX Corp.

Provide ROCE
for Cell MedX Corp.

Provide Gross Margin
for Cell MedX Corp.

Provide Operating Margin
for Cell MedX Corp.

Provide Net Margin
for Cell MedX Corp.

Provide FCF Margin
for Cell MedX Corp.

Show all solvency ratios
for Cell MedX Corp.

Provide D/E Ratio
for Cell MedX Corp.

Provide D/A Ratio
for Cell MedX Corp.

Provide Interest Coverage Ratio
for Cell MedX Corp.

Provide Altman Z-Score Ratio
for Cell MedX Corp.

Provide Quick Ratio
for Cell MedX Corp.

Provide Current Ratio
for Cell MedX Corp.

Provide Cash Ratio
for Cell MedX Corp.

What is the historical Revenue growth
over the last 5 years for Cell MedX Corp?

What is the historical Net Income growth
over the last 5 years for Cell MedX Corp?

What is the current Free Cash Flow
of Cell MedX Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Cell MedX Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cell MedX Corp

Current Assets 46.1k
Cash & Short-Term Investments 43.4k
Other Current Assets 2.7k
Current Liabilities 872.6k
Accounts Payable 288.9k
Accrued Liabilities 28.1k
Short-Term Debt 324.5k
Other Current Liabilities 231.1k
Efficiency

Earnings Waterfall
Cell MedX Corp

Revenue
0 USD
Operating Expenses
-268.4k USD
Operating Income
-268.4k USD
Other Expenses
125.9k USD
Net Income
-142.5k USD

Free Cash Flow Analysis
Cell MedX Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CMXC Profitability Score
Profitability Due Diligence

Cell MedX Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional 3-Year Average ROE
Exceptional ROIC
Positive ROE
50/100
Profitability
Score

Cell MedX Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

CMXC Solvency Score
Solvency Due Diligence

Cell MedX Corp's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Low D/E
Positive Net Debt
Short-Term Solvency
Long-Term Solvency
28/100
Solvency
Score

Cell MedX Corp's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CMXC Price Targets Summary
Cell MedX Corp

There are no price targets for CMXC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CMXC?

Click here to dive deeper.

Dividends

Cell MedX Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for CMXC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CMXC Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Cell MedX Corp Logo
Cell MedX Corp

Country

United States of America

Industry

Health Care

Market Cap

40B USD

Dividend Yield

0%

Description

Cell MedX Corp. is a biotech company, which engages in the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness. The company is headquartered in Carson City, Nevada. The company went IPO on 2013-03-11. The Company, through its subsidiary, is engaged in developing and manufacturing therapeutic devices based on its proprietary eBalance technology, which harnesses the power of microcurrents and its effects on the human body. The Company’s eBalance Pro System and eBalance Home System, are microcurrent electrotherapy systems intended to administer a specific variety of therapeutic microcurrent algorithms for temporary relief of pain associated with sore/aching muscles in the shoulders, waist, back, neck, upper extremities (arms) and lower extremities (legs) due to strain from exercise or normal household- or work-related activities, as well as for general relaxation.

Contact

NEVADA
Carson City
123 W Nye Ln Ste 446
+18442382692.0
cellmedx.com

IPO

2013-03-11

Employees

-

Officers

President, CEO & Director
Mr. David M. Jeffs
CFO, Treasurer, Corporate Secretary & Director
Ms. Yanika Silina C.M.A., CPA

See Also

Discover More